Sandoz Group AG
ISIN: CH1243598427 | Ticker: SDZ | LEI: 549300X7ELPSP81ATF17
Country: Switzerland
Sandoz operates in the attractive and growing global off-patent medicines market, which benefits from a growing and aging population, higher rates of chronic disease, increasing market adoption as healthcare systems and payors seek to reduce the cost of medicines, and a consistent supply of upcoming loss of exclusivities (LoEs) as patents for originator products expire. Together, these drivers are expected to support long-term growth in volumes that will more than offset anticipated erosion in price.
Year founded1886
Served areaWorldwide
HeadquartersSuurstoffi 14, 6343 Rotkreuz – Switzerland
| Date | Trading entity / Person | Association | Trade type | Volume |
|---|---|---|---|---|
| 10.11.23 | None | Non-Executive member | Buy | CHF 84,583.00 |
| 10.11.23 | None | Non-Executive member | Buy | CHF 72,917.00 |
| 10.11.23 | None | Non-Executive member | Buy | CHF 13,417.00 |
| 25.10.23 | None | Executive member | Buy | CHF 486,590.00 |
CH1243598427
LEI549300X7ELPSP81ATF17
SectorHealth Care Equipment & Services
IndustryHealth Care Providers & Services
Sub-IndustryKeep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.